The biggest US tech stocks have enjoyed an earnings bonanza in the past two years, leading to their significant ...

A new U.K. study led by the University of Liverpool has examined whether an additional blood test called procalcitonin (PCT) ...

Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad ...

Shares of Catalyst Pharmaceuticals CPRX gained 16.7% on Wednesday after the company, along with its licensor, SERB, announced ...

Children are at greater risk for frost-bite than adults. The best way to prevent frostbite is to make sure children dress ...

For patients with severe elevations in low-density lipoprotein (LDL) cholesterol (≥190 mg/dL) and a combination of clinical ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel, first-in-class biologic therapy ...